Wall Street Analysts See a 258.38% Upside in Vir Biotechnology (VIR): Can the Stock Really Move This High?

Vir Biotechnology, Inc. (VIR) closed the last trading session at $8.65, gaining 2.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $31 indicates a 258.4% upside potential. The mean estimate comprises eight short-term price targets with a standard deviation of $32.37. While the lowest estimate of $13 indicates a 50.3% increase from the current price level, the most optimistic anal ...